+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Patient Engagement Solution Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 250 Pages
  • July 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5986719
Patient engagement solutions are becoming integral to the healthcare system, enabling patients, clinicians, and other stakeholders to collaborate effectively to enhance healthcare outcomes. In 2024, the market for patient engagement solutions is valued at $21.12 billion and is projected to reach $51.15 billion by 2031, growing at a compound annual growth rate (CAGR) of 13.50%. These solutions provide patients with real-time access to their health records, dosages, and medications, allowing them to manage their healthcare alongside their consultants. The software’s benefits include cost-effective healthcare, improved patient outreach, fewer complications, reduced hospital readmission rates, shorter hospital stays, and enhanced healthcare quality. However, patient engagement strategies require further development to motivate increased patient participation in education.

The global market for patient engagement solutions is driven by several factors, including rising government spending on healthcare and prescription drugs, increased smartphone usage in healthcare, and growing investments and alliances among stakeholders. Additionally, the aging population and the prevalence of chronic diseases are prompting the creation of these solutions worldwide. Government regulations and initiatives focused on patient-centric care are expected to further fuel market growth. Governments globally are implementing policies and programs to encourage the adoption of patient engagement technologies. The increasing use of cloud-based systems in healthcare facilities and advancements in wearable health technology and other innovations are also creating new opportunities for market expansion. The shift towards value-based healthcare programs, which lead to better health outcomes, lower healthcare costs, and higher patient satisfaction, is anticipated to support market growth.

Regional Market Insights

North America holds a leading position in the global patient engagement solution market, with significant demand expected to continue throughout the forecast period. The European market is also notable, with a substantial share of the global market. These regions are likely to maintain their dominance due to advanced healthcare infrastructure and supportive government policies.

Growth Restraints

The growth of the patient engagement solution market faces certain restraints. One major challenge is the high investment required for implementing these solutions. Organizations need to invest in proprietary systems and infrastructure, which can be costly. Furthermore, existing systems must be modified to accommodate new technologies, particularly cloud-based patient engagement solutions. This is especially true for hospitals that already function as hubs connecting multiple physician labs and clinics. The transition to new systems may require significant changes to the current IT architecture, posing another obstacle.

Recent Developments

Recent developments in the market include several strategic agreements and technological upgrades. For example, Allied Digestive Health (ADH) selected Athenahealth's cloud-based healthcare payment and patient engagement solutions to enhance patient relations and revenue cycle management. Another example is Happydemic, which upgraded its cloud Analysis with the implementation of SAP Business by Design, a comprehensive cloud enterprise resource planning (ERP) system.

Market Dynamics in the U.S.

The U.S. is a key market for patient engagement solutions within North America, with significant developments driven by government initiatives promoting patient-centric care. These initiatives enhance the flexibility for Medicare to protect telehealth services and authorize home health services by various healthcare professionals. Additionally, Medicare payments for hospitals and medical equipment have increased, further supporting market growth.

Opportunities in Japan

The patient engagement solution market in Japan offers substantial growth opportunities, driven by technological advancements in healthcare and supportive government initiatives. The country's rising expenditure on healthcare facilities and the presence of skilled IT experts also contribute to market expansion. Innovations in artificial intelligence (AI), the Internet of Things (IoT), and other technologies are expected to boost the adoption of patient engagement solutions in Japan.

Europe's Market Analysis

In Europe, the adoption of home healthcare management services is particularly notable in Germany. Advanced patient engagement solutions enable patients to manage appointments, pay bills online, and communicate with healthcare providers from the comfort of their homes. This growing adoption is expected to drive market growth in Germany and other parts of Europe.

Category-wise Insights

The patient engagement solution market is segmented into software and services. The software segment includes integrated patient software and standalone software, with the latter accounting for a significant share of the market. Standalone software’s seamless integration with electronic medical records provides users with real-time clinical intelligence, making it suitable for both clinicians and patients.

In terms of deployment, the market is divided into on-premise and cloud segments. On-premise solutions hold a major share of the market due to the secure management of information within the premises and the organization’s infrastructure handling software installation and use. This deployment model is expected to maintain its position over the forecast period.

Competitive Analysis

Leading companies in the patient engagement solution market are engaging in collaborations and partnerships to enhance their offerings. For instance, McKesson announced a strategic agreement with Merck to leverage real-world evidence for improving patient outcomes and developing cancer treatments. Similarly, Humana collaborated with IBM to deploy IBM Watson Assistant for Health Benefits, an AI-enabled virtual agent that enhances member experience by providing clarity and transparency on benefits and related matters.

Key Companies Profiled

The patient engagement solution market includes several prominent players, such as:

  • Allscripts Healthcare Solutions
  • McKesson Corporation
  • Cerner Corporation
  • Phytel Inc
  • Medecision Inc
  • Athenahealth, Inc.
  • Novartis
  • Roche Holding AG
  • Bayer
  • GlaxoSmithKline
  • IQVIA

Key Segments of Patient Engagement Solution Market Industry Research

By Solution:

  • Software
  • Integrated Patient Software
  • Standalone Software
  • Scheduling Software
  • Billing Software
  • Secure Messaging Software
  • Others
  • Services
  • Implementation and Integration
  • Consulting
  • Support & Maintenance

By Deployment:

  • Cloud
  • On Premise

By Application:

  • Health Management
  • Social Management
  • Home Healthcare Management
  • Financial Health Management
  • Others

By End User:

  • Patients
  • Payers
  • Healthcare Providers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Patient Engagement Solution Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Economic Overview
2.6.1. World Economic Projections
2.7. PESTLE Analysis
3. Global Patient Engagement Solution Market Outlook, 2019-2031
3.1. Global Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
3.1.1. Key Highlights
3.1.1.1. Software
3.1.1.1.1. Integrated Patient Software
3.1.1.1.2. Standalone Software
3.1.1.1.2.1. Scheduling Software
3.1.1.1.2.2. Billing Software
3.1.1.1.2.3. Secure Messaging Software
3.1.1.1.2.4. Others
3.1.1.2. Services
3.1.1.2.1. Implementation and Integration
3.1.1.2.2. Consulting
3.1.1.2.3. Support & Maintenance
3.2. Global Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
3.2.1. Key Highlights
3.2.1.1. Cloud
3.2.1.2. On Premise
3.3. Global Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
3.3.1. Key Highlights
3.3.1.1. Health Management
3.3.1.2. Social Management
3.3.1.3. Home Healthcare Management
3.3.1.4. Financial Health Management
3.3.1.5. Others
3.4. Global Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
3.4.1. Key Highlights
3.4.1.1. Patients
3.4.1.2. Payers
3.4.1.3. Healthcare Providers
3.4.1.4. Others
3.5. Global Patient Engagement Solution Market Outlook, by Region, Value (US$ Bn), 2019-2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Patient Engagement Solution Market Outlook, 2019-2031
4.1. North America Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
4.1.1. Key Highlights
4.1.1.1. Software
4.1.1.1.1. Integrated Patient Software
4.1.1.1.2. Standalone Software
4.1.1.1.2.1. Scheduling Software
4.1.1.1.2.2. Billing Software
4.1.1.1.2.3. Secure Messaging Software
4.1.1.1.2.4. Others
4.1.1.2. Services
4.1.1.2.1. Implementation and Integration
4.1.1.2.2. Consulting
4.1.1.2.3. Support & Maintenance
4.2. North America Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
4.2.1. Key Highlights
4.2.1.1. Cloud
4.2.1.2. On Premise
4.3. North America Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
4.3.1. Key Highlights
4.3.1.1. Health Management
4.3.1.2. Social Management
4.3.1.3. Home Healthcare Management
4.3.1.4. Financial Health Management
4.3.1.5. Others
4.4. North America Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
4.4.1. Key Highlights
4.4.1.1. Patients
4.4.1.2. Payers
4.4.1.3. Healthcare Providers
4.4.1.4. Others
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
4.5.1. Key Highlights
4.5.1.1. U.S. Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
4.5.1.2. U.S. Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
4.5.1.3. U.S. Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
4.5.1.4. U.S. Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
4.5.1.5. Canada Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
4.5.1.6. Canada Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
4.5.1.7. Canada Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
4.5.1.8. Canada Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Patient Engagement Solution Market Outlook, 2019-2031
5.1. Europe Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
5.1.1. Key Highlights
5.1.1.1. Software
5.1.1.1.1. Integrated Patient Software
5.1.1.1.2. Standalone Software
5.1.1.1.2.1. Scheduling Software
5.1.1.1.2.2. Billing Software
5.1.1.1.2.3. Secure Messaging Software
5.1.1.1.2.4. Others
5.1.1.2. Services
5.1.1.2.1. Implementation and Integration
5.1.1.2.2. Consulting
5.1.1.2.3. Support & Maintenance
5.2. Europe Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
5.2.1. Key Highlights
5.2.1.1. Cloud
5.2.1.2. On Premise
5.3. Europe Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
5.3.1. Key Highlights
5.3.1.1. Health Management
5.3.1.2. Social Management
5.3.1.3. Home Healthcare Management
5.3.1.4. Financial Health Management
5.3.1.5. Others
5.4. Europe Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
5.4.1. Key Highlights
5.4.1.1. Patients
5.4.1.2. Payers
5.4.1.3. Healthcare Providers
5.4.1.4. Others
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
5.5.1. Key Highlights
5.5.1.1. Germany Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
5.5.1.2. Germany Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
5.5.1.3. Germany Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
5.5.1.4. Germany Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
5.5.1.5. U.K. Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
5.5.1.6. U.K. Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
5.5.1.7. U.K. Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
5.5.1.8. U.K. Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
5.5.1.9. France Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
5.5.1.10. France Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
5.5.1.11. France Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
5.5.1.12. France Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
5.5.1.13. Italy Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
5.5.1.14. Italy Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
5.5.1.15. Italy Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
5.5.1.16. Italy Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
5.5.1.17. Turkey Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
5.5.1.18. Turkey Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
5.5.1.19. Turkey Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
5.5.1.20. Turkey Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
5.5.1.21. Russia Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
5.5.1.22. Russia Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
5.5.1.23. Russia Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
5.5.1.24. Russia Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
5.5.1.25. Rest of Europe Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
5.5.1.26. Rest of Europe Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
5.5.1.27. Rest of Europe Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
5.5.1.28. Rest of Europe Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Patient Engagement Solution Market Outlook, 2019-2031
6.1. Asia Pacific Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
6.1.1. Key Highlights
6.1.1.1. Software
6.1.1.1.1. Integrated Patient Software
6.1.1.1.2. Standalone Software
6.1.1.1.2.1. Scheduling Software
6.1.1.1.2.2. Billing Software
6.1.1.1.2.3. Secure Messaging Software
6.1.1.1.2.4. Others
6.1.1.2. Services
6.1.1.2.1. Implementation and Integration
6.1.1.2.2. Consulting
6.1.1.2.3. Support & Maintenance
6.2. Asia Pacific Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
6.2.1. Key Highlights
6.2.1.1. Cloud
6.2.1.2. On Premise
6.3. Asia Pacific Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
6.3.1. Key Highlights
6.3.1.1. Health Management
6.3.1.2. Social Management
6.3.1.3. Home Healthcare Management
6.3.1.4. Financial Health Management
6.3.1.5. Others
6.4. Asia Pacific Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
6.4.1. Key Highlights
6.4.1.1. Patients
6.4.1.2. Payers
6.4.1.3. Healthcare Providers
6.4.1.4. Others
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
6.5.1. Key Highlights
6.5.1.1. China Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
6.5.1.2. China Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
6.5.1.3. China Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
6.5.1.4. China Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
6.5.1.5. Japan Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
6.5.1.6. Japan Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
6.5.1.7. Japan Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
6.5.1.8. Japan Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
6.5.1.9. South Korea Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
6.5.1.10. South Korea Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
6.5.1.11. South Korea Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
6.5.1.12. South Korea Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
6.5.1.13. India Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
6.5.1.14. India Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
6.5.1.15. India Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
6.5.1.16. India Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
6.5.1.17. Southeast Asia Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
6.5.1.18. Southeast Asia Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
6.5.1.19. Southeast Asia Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
6.5.1.20. Southeast Asia Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
6.5.1.21. Rest of Asia Pacific Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
6.5.1.22. Rest of Asia Pacific Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
6.5.1.23. Rest of Asia Pacific Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
6.5.1.24. Rest of Asia Pacific Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Patient Engagement Solution Market Outlook, 2019-2031
7.1. Latin America Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
7.1.1. Key Highlights
7.1.1.1. Software
7.1.1.1.1. Integrated Patient Software
7.1.1.1.2. Standalone Software
7.1.1.1.2.1. Scheduling Software
7.1.1.1.2.2. Billing Software
7.1.1.1.2.3. Secure Messaging Software
7.1.1.1.2.4. Others
7.1.1.2. Services
7.1.1.2.1. Implementation and Integration
7.1.1.2.2. Consulting
7.1.1.2.3. Support & Maintenance
7.2. Latin America Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
7.2.1.1. Cloud
7.2.1.2. On Premise
7.3. Latin America Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
7.3.1. Key Highlights
7.3.1.1. Health Management
7.3.1.2. Social Management
7.3.1.3. Home Healthcare Management
7.3.1.4. Financial Health Management
7.3.1.5. Others
7.4. Latin America Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
7.4.1. Key Highlights
7.4.1.1. Patients
7.4.1.2. Payers
7.4.1.3. Healthcare Providers
7.4.1.4. Others
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
7.5.1. Key Highlights
7.5.1.1. Brazil Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
7.5.1.2. Brazil Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
7.5.1.3. Brazil Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
7.5.1.4. Brazil Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
7.5.1.5. Mexico Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
7.5.1.6. Mexico Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
7.5.1.7. Mexico Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
7.5.1.8. Mexico Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
7.5.1.9. Argentina Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
7.5.1.10. Argentina Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
7.5.1.11. Argentina Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
7.5.1.12. Argentina Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
7.5.1.13. Rest of Latin America Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
7.5.1.14. Rest of Latin America Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
7.5.1.15. Rest of Latin America Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
7.5.1.16. Rest of Latin America Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Patient Engagement Solution Market Outlook, 2019-2031
8.1. Middle East & Africa Patient Engagement Solution Market Outlook, by Solution, Value (US$ Bn), 2019-2031
8.1.1. Key Highlights
8.1.1.1. Software
8.1.1.1.1. Integrated Patient Software
8.1.1.1.2. Standalone Software
8.1.1.1.2.1. Scheduling Software
8.1.1.1.2.2. Billing Software
8.1.1.1.2.3. Secure Messaging Software
8.1.1.1.2.4. Others
8.1.1.2. Services
8.1.1.2.1. Implementation and Integration
8.1.1.2.2. Consulting
8.1.1.2.3. Support & Maintenance
8.2. Middle East & Africa Patient Engagement Solution Market Outlook, by Development, Value (US$ Bn), 2019-2031
8.2.1. Key Highlights
8.2.1.1. Cloud
8.2.1.2. On Premise
8.3. Middle East & Africa Patient Engagement Solution Market Outlook, by Application, Value (US$ Bn), 2019-2031
8.3.1. Key Highlights
8.3.1.1. Health Management
8.3.1.2. Social Management
8.3.1.3. Home Healthcare Management
8.3.1.4. Financial Health Management
8.3.1.5. Others
8.4. Middle East & Africa Patient Engagement Solution Market Outlook, by End User, Value (US$ Bn), 2019-2031
8.4.1. Key Highlights
8.4.1.1. Patients
8.4.1.2. Payers
8.4.1.3. Healthcare Providers
8.4.1.4. Others
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Patient Engagement Solution Market Outlook, by Country, Value (US$ Bn), 2019-2031
8.5.1. Key Highlights
8.5.1.1. GCC Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
8.5.1.2. GCC Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
8.5.1.3. GCC Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
8.5.1.4. GCC Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
8.5.1.5. South Africa Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
8.5.1.6. South Africa Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
8.5.1.7. South Africa Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
8.5.1.8. South Africa Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
8.5.1.9. Egypt Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
8.5.1.10. Egypt Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
8.5.1.11. Egypt Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
8.5.1.12. Egypt Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
8.5.1.13. Nigeria Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
8.5.1.14. Nigeria Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
8.5.1.15. Nigeria Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
8.5.1.16. Nigeria Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
8.5.1.17. Rest of Middle East & Africa Patient Engagement Solution Market by Solution, Value (US$ Bn), 2019-2031
8.5.1.18. Rest of Middle East & Africa Patient Engagement Solution Market by Development, Value (US$ Bn), 2019-2031
8.5.1.19. Rest of Middle East & Africa Patient Engagement Solution Market by Application, Value (US$ Bn), 2019-2031
8.5.1.20. Rest of Middle East & Africa Patient Engagement Solution Market by End User, Value (US$ Bn), 2019-2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2024
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Allscripts Healthcare Solutions
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. McKesson Corporation
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. Cerner Corporation
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Phytel Inc
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Medecision Inc
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Athenahealth, Inc.
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Novartis
9.3.7.1. Company Overview
9.3.7.2. Product Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Roche Holding AG
9.3.8.1. Company Overview
9.3.8.2. Product Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Bayer
9.3.9.1. Company Overview
9.3.9.2. Product Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
9.3.10. Others
9.3.10.1. Company Overview
9.3.10.2. Product Portfolio
9.3.10.3. Financial Overview
9.3.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Allscripts Healthcare Solutions
  • Mckesson Corporation
  • Cerner Corporation
  • Phytel Inc
  • Medecision Inc
  • Athenahealth Inc
  • Novartis
  • Roche Holding AG
  • Bayer
  • GlaxoSmithkline
  • IQVIA

Methodology

Loading
LOADING...